Rothlin Is Appointed McConnell Duberg Professor
Carla Vanina Rothlin, PhD, newly named as Dorys McConnell Duberg Professor of Immunobiology, studies the mechanisms that regulate the magnitude and resolution of the immune response. Rothlin is also a professor of pharmacology, a member of the Yale Cancer Center, and a Howard Hughes Faculty Scholar.
Picciotto to be Recognized with Marion Spencer Fay Award
The Institute for Women’s Health and Leadership of Drexel University College of Medicine will award its 2020 Marion Spencer Fay Award to Marina Picciotto, PhD, Charles B.G. Murphy Professor of Psychiatry and Professor in the Child Study Center, of Neuroscience and of Pharmacology at Yale School of Medicine.
Yale Cancer Center and Smilow Cancer Hospital physicians recognized as CT Magazine 'Best Doctors'
Connecticut Magazine has named 72 Yale Cancer Center and Smilow Cancer Hospital physicians to its 2019 Best Doctors guide. Published in the magazine’s June issue, the Best Doctors list consists of 782 Connecticut physicians from 78 medical specialties.
New strategy for untreatable kidney disease: targeting cell energy
The best hope for people with an inherited form of kidney disease that causes kidney failure is dialysis or a kidney transplant. But a study led by Yale researchers reveals a potential strategy for developing new drug therapies for these patients.
North American Vascular Biology Organization Honors Eichmann and Sessa
The North American Vascular Biology Organization will give its Judah Folkman Award in Vascular Biology to Anne Eichmann, PhD, Ensign Professor of Medicine (Cardiology) and professor of cellular and molecular physiology; and its Earl P. Benditt Award to William Sessa, PhD, Alfred Gilman Professor of Pharmacology and professor of medicine (cardiology).
William Sessa selected as the 2019 recipient of the Earl P. Benditt Award
The NAVBO Meritorious Awards Committee and Council is pleased to announce the selection of William Sessa, PhD, as the 2019 recipient of the Earl P. Benditt Award, in recognition of his numerous contributions to our understanding of mechanisms regulating nitric oxide production in the vascular endothelium.
Yale Cancer Center researchers find genetic explanations behind the rapid spread of ovarian cancer
In a breakthrough study, Yale Cancer Center (YCC) researchers have defined the genetic characteristics of primary, metastatic and recurrent ovarian tumors and evaluated new targeted therapies to treat the disease. The findings are reported today in the Proceedings of the National Academy of Science (PNAS) online early edition.
Addicted to vaped nicotine, teenagers have no clear path to quitting
Marina Picciotto, PhD, Charles B.G. Murphy Professor of Psychiatry and Professor in the Child Study Center, of Neuroscience and of Pharmacology, discusses the impact of exposing the brain's prefrontal cortex to nicotine in a New York Times report on teenage vaping.
Yale Cancer Center Experts and U.S. Senators Discuss Breakthroughs and Barriers in Research and Care
Democrats and Republicans may be far apart on a number of issues, but during a September 21st Cancer Community Town Hall at Yale New Haven Hospital, U.S. Sen. Chris Murphy said there’s at least one key initiative that’s received bipartisan support for more than two decades.
$20 Million Grant Will Fund Continued Research by Yale Tobacco Center of Regulatory Science
The National Institute of Health and the U.S. Food and Drug Administration have renewed a $20 million grant for the Yale Tobacco Center of Regulatory Science (TCORS) to continue to investigate the influence of flavors and sweeteners, and other constituents, on the appeal and addictive potential of traditional tobacco products and newer products like e-cigarettes.